A new study led by investigators from Mass General Cancer Center reveals that statins—commonly used cholesterol-lowering drugs—may block a particular pathway involved in the development of cancer that results from chronic inflammation. The findings are published in Nature Communications.

Related Keywords

United States , Massachusetts , America , Shawn Demehri , Research Scholar , Nature Communications , Cutaneous Biology Research Center , Dermatology At Harvard Medical School , Cancer Center , Drug Administration , Mass General Cancer Center , Cancer Immunology , Massachusetts General Hospital , Harvard Medical , Rita Davis Family , North America ,